Q1 2017

Filed May 17, 2017 · 10-Q · 47 days after period end · 0001398432-17-000086

Q1 2017 · 10-Q

Revenue

$16.98K

−54.6% vs Q1 2016

Net Income

-$940.14K

N/M vs Q1 2016

EPS Diluted

-$0.02

N/M vs Q1 2016

Gross Profit$9,185−69.3%

Operating Income

Same quarter

Metric	Q1 2017	Q1 2016	Q1 2015	Q1 2014
Revenue	$16.98K	$37.39K	$121.00K	$54.75K
Net Income	-$940.14K	-$1.07M	-$364.01K	-$206.91K
EPS Diluted	-$0.02	-$0.01	-$0.01	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR